Cholangiocarcinoma: The Current Status of Surgical Options including Liver Transplantation

Abdullah Esmail,Mohamed Badheeb,Batool Alnahar,Bushray Almiqlash,Yara Sakr,Bayan Khasawneh,Ebtesam Al-Najjar,Hadeel Al-Rawi,Ala Abudayyeh,Yaser Rayyan,Maen Abdelrahim

DOI: https://doi.org/10.3390/cancers16111946

2024-05-22

Cancers

Abstract:Cholangiocarcinoma (CCA) poses a substantial threat as it ranks as the second most prevalent primary liver tumor. The documented annual rise in intrahepatic CCA (iCCA) incidence in the United States is concerning, indicating its growing impact. Moreover, the five-year survival rate after tumor resection is only 25%, given that tumor recurrence is the leading cause of death in 53–79% of patients. Pre-operative assessments for iCCA focus on pinpointing tumor location, biliary tract involvement, vascular encasements, and metastasis detection. Numerous studies have revealed that portal vein embolization (PVE) is linked to enhanced survival rates, improved liver synthetic functions, and decreased overall mortality. The challenge in achieving clear resection margins contributes to the notable recurrence rate of iCCA, affecting approximately two-thirds of cases within one year, and results in a median survival of less than 12 months for recurrent cases. Nearly 50% of patients initially considered eligible for surgical resection in iCCA cases are ultimately deemed ineligible during surgical exploration. Therefore, staging laparoscopy has been proposed to reduce unnecessary laparotomy. Eligibility for orthotopic liver transplantation (OLT) requires certain criteria to be granted. OLT offers survival advantages for early-detected unresectable iCCA; it can be combined with other treatments, such as radiofrequency ablation and transarterial chemoembolization, in specific cases. We aim to comprehensively describe the surgical strategies available for treating CCA, including the preoperative measures and interventions, alongside the current options regarding liver resection and OLT.

oncology

What problem does this paper attempt to address?

The paper primarily explores the current surgical treatment strategies for cholangiocarcinoma (CCA), including surgical options such as liver transplantation. CCA is a severe disease and the second most common type of primary liver tumor, posing a significant threat to patients' health. The core objective of the paper is to comprehensively describe the surgical treatment methods for CCA, including preoperative assessment measures, intervention methods, and current options for liver resection and orthotopic liver transplantation (OLT).

Specifically, the paper addresses the following key issues:
1. **Disease Background and Challenges**: CCA is highly aggressive, with a 5-year survival rate as low as 5% (in cases with lymph node positivity). Even with tumor resection, the 5-year survival rate is only about 25%. Tumor recurrence is the main cause of patient mortality, typically occurring within 2 years post-surgery.
2. **Preoperative Assessment**: Preoperative assessment is crucial for determining the optimal treatment plan. This includes identifying tumor location, bile duct involvement, vascular invasion, and metastasis detection. Common assessment methods include carbohydrate antigen (CA19-9) testing, enhanced CT scans, or MRI examinations.
3. **Surgical Management**: The paper discusses various surgical management approaches for CCA, including but not limited to:
- **Preoperative Interventions**: Such as staging laparoscopy to avoid unnecessary laparotomy; preoperative biliary drainage to improve liver function; preoperative portal vein embolization (PVE) to promote the growth of the remaining liver tissue.
- **Liver Resection**: Depending on the tumor location, different types of liver resection may be required. For example, for iCCA (intrahepatic cholangiocarcinoma), it usually involves negative margin resection of the affected liver segment or lobe, with concurrent lymph node dissection recommended. For pCCA (perihilar cholangiocarcinoma), complex vascular reconstruction may also be necessary.
- **Liver Transplantation**: For certain early-detected and unresectable iCCA patients, OLT can be a treatment option. Precise patient selection criteria are crucial for improving post-OLT survival rates.

In summary, the paper aims to provide guidance to clinicians and researchers through a comprehensive analysis of existing surgical treatment methods, with the goal of improving treatment outcomes and quality of life for CCA patients.